Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 29.04.2026 QCLN.LN IE00BDBRT036 1,150,002.00 USD 25,029,163.82 21.764 ...
-
Intercontinental Exchange Approves Second Quarter Dividend of $0.52 per Share
ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange (NYSE: ICE), one of the world’s leading providers of financial market technology and data powering global capital markets, announced today a $0.52 per share dividend for the second quarter of 2026, which is up 8% from the $0.48 per share dividend paid in the second quarter of 2025. The cash dividend is payable on June 30, 2026 to stockholders of record as of June 15, 2026. The ex-dividend date is June 15, 2026. About Intercontinenta...
-
Acadian Asset Management Inc. Reports Financial and Operating Results for the First Quarter Ended March 31, 2026
BOSTON--(BUSINESS WIRE)--Acadian Asset Management Inc. (NYSE: AAMI) today announced its results for the first quarter ended March 31, 2026. Acadian Asset Management Inc.’s earnings presentation is available at: ir.acadian-inc.com The Company will hold a conference call and simultaneous webcast to discuss the results at 11:00 a.m. Eastern Time today. To listen to the call or view the webcast, participants should: Dial-in Local Dial-in Number: (585) 542 9983 Toll Free Dial-i...
-
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the launch of its Reimagine Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) campaign for AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets), the first and only treatment specifically approved by the U.S. Food and Drug Administration (FDA) for adult patients with KRAS-mutated recurrent...
-
Distribution Solutions Group Announces 2026 First Quarter Results
FORT WORTH, Texas--(BUSINESS WIRE)--Distribution Solutions Group, Inc. (NASDAQ:DSGR) ("DSG" or the "Company"), a premier specialty distribution company, today announced consolidated results for the first quarter ended March 31, 2026. This press release is supplemented by an earnings presentation at https://investor.distributionsolutionsgroup.com/news/events. The following represents a summary of certain operating results (unaudited). See the reconciliations of GAAP to non-GAAP measures in Table...
-
SRM Appoints Shana Hennigan Executive Vice President of Client Strategy
MEMPHIS, Tenn.--(BUSINESS WIRE)--SRM announces that Shana Hennigan has joined the firm as Executive Vice President of Client Strategy....
-
World Acceptance Corporation Reports Fiscal 2026 Fourth Quarter Results
GREENVILLE, S.C.--(BUSINESS WIRE)--World Acceptance Corporation (NASDAQ: WRLD) today reported financial results for its fourth quarter of fiscal 2026. Fourth fiscal quarter highlights Following a period of economic uncertainty and elevated inflation, the Company took decisive action to tighten underwriting standards dramatically in an effort to manage conservatively through the lending environment and focus on improvement to overall portfolio credit quality. As a result, outstanding balances de...
-
Lincoln Electric Reports First Quarter 2026 Results
CLEVELAND--(BUSINESS WIRE)--Lincoln Electric reports record first quarter 2026 Net sales and Adjusted EPS results....
-
Organon Reports Results for the First Quarter Ended March 31, 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue in $ millions Q1 2026 Q1 2025 VPY VPY ex-FX Women’s Health $ 389 $ 463 (16)% (19)% General Medicines Biosimilars 173 141 23% 21% Established Brands 880 887 (1)% (7)% Other (1) 18 22 (15)% (21)% Revenue $ 1,460 $ 1,513 (4)% (9)% Totals may not foot due to rounding...
-
VSE Corporation Announces May 2026 Investor Conference Schedule
MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that VSE Corporation’s senior management will participate in the following upcoming conferences. B. Riley Securities 26th Annual Investor Conference in Marina del Rey, CA on May 20th. John Cuomo, President and CEO of VSE Corporation and Michael Perlman, VP of Investor Relations and Treasury are scheduled to particip...